Last reviewed · How we verify
NCT07503977
Acute Physiological Effects of Full-Body Far-Infrared Emitting Textiles on Young Road Cyclists
NA trial testing FIR in Athletes in 9 participants. Completed in 25 June 2025.
25 June 2025
Quick facts
| Lead sponsor | University of Palermo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 9 |
| Start date | 15 April 2025 |
| Primary completion | 25 June 2025 |
| Estimated completion | 25 June 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- FIR — full drug profile →
- Placebo
Conditions studied
Sponsor
University of Palermo
Who can join
Adults 16 to 18, any sex, with Athletes or Cyclists. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Road cycling is a sport characterized by long, high-intensity training sessions. Cyclists train and compete in varying temperatures, which can affect their performance. Therefore, thermoregulation is a fundamental capacity in endurance sports such as cycling. Far-infrared (FIR) emitting fibers have recently been used in garments during and after exercise to modulate thermoregulation and enhance muscle recovery. Every competitive cyclist voluntarily underwent testing at a temperature-controlled laboratory after reading and signing the informed consent document. Participants were invited to three separate sessions at the laboratory. During the first session, essential personal information (name, surname, sex, age, height and weight) was recorded. In addition, an incremental test was performed on a cycle ergometer to measure VO2Max and ventilatory threshold 1 (VT1). Subsequently, they were randomly divided into two conditions: an experimental garment (EG) with FIR and a control garment (CG). Each test session consisted of 40 minutes at VT1, followed by a 5-second sprint at the end. During the test, various physiological parameters were assessed: Oxygen consumption (VO2), heart rate (HR), blood lactate, body temperature (skin and core temperature), and sensations of exertion and sweating.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07503977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FIR
Trials testing the same drug.
- NCT03449446 — Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With · Phase 2 · completed
- NCT02781584 — Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatiti · Phase 2 · completed
Other recruiting trials for Athletes
Currently open trials in the same condition.
- NCT07133841 — Validity of Thermal Imaging in Injury Risk Assessment in Volleyball Players · recruiting
- NCT06803979 — Impact of Delivery Method Elite Athletes. · recruiting
- NCT05936840 — Quantum Menstrual Health Monitoring Study · recruiting
- NCT06377306 — Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes · recruiting
- NCT06017180 — Effects of Myofascial Release Technique on Mobility, Sensorimotor Function and Performance in Volleyball Players · NA · recruiting
Other University of Palermo trials
Trials by the same sponsor.
- NCT03017716 — Inflammatory Back Pain and Gluten Free Diet · NA · not yet recruiting
- NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
- NCT06206616 — Liver Steatosis in Pediatric CD Patients · not yet recruiting
- NCT07433543 — Foam Rolling, Blood Pressure and Range of Motion · NA · completed
- NCT07213011 — Effects of Static Stretching and Self-myofascial Release on Local and Remote Range of Motion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07503977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Palermo
- Last refreshed: 31 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07503977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing